Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer

被引:145
作者
Seppenwoolde, Y [1 ]
De Jaeger, K [1 ]
Boersma, LJ [1 ]
Belderbos, JSA [1 ]
Lebesque, JV [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 03期
关键词
radiation pneumonitis; NTCP; lung cancer; radiotherapy;
D O I
10.1016/j.ijrobp.2004.04.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study regional differences in lung radiosensitivity by evaluating the incidence of radiation pneumonitis (RP) in relation to regional dose distributions. Methods and Materials: Registered chest CT and single photon emission CT lung perfusion scans were obtained in 106 patients before curative or radical radiotherapy for non-small-cell lung cancer. The mean lung dose (MLD) was calculated. The single photon-emission CT perfusion data were used to weigh the MLD with perfusion, resulting in the mean perfusion-weighted lung dose. In addition, the lungs were geometrically divided into different subvolumes. The mean regional dose (MRD) for each region was calculated and weighted with the perfusion of each region to obtain the mean perfusion-weighted regional dose. RP was defined as respiratory symptoms requiring steroids. The incidence of RP for patients with tumors in a specific subvolume was calculated. The normal tissue complication probability (NTCP) parameter values for the TD50, and an offset NTCP parameter for tumor location were fitted for both lungs and for each lung subvolume to the observed data using maximum likelihood analysis. Results: The incidence of RP correlated significantly with the MLD and MRD of the posterior, caudal, ipsilateral, central, and peripheral lung subvolumes (p between 0.05 and 0.002); no correlation was seen for the anterior, cranial, and contralateral regions Similarly, a statistically significant correlation was observed between the incidence of RP and the perfusion-weighted MLD and perfusion-weighted MRD for all regions, except the anterior lung region. For this region, the dose-effect relation improved remarkably after weighting the local dose with the local perfusion. A statistically significant difference (p = 0.01) in the incidence of RP was found between patients with cranial and caudal tumors (11% and 40%, respectively). Therefore, a dose-independent offset NTCP parameter for caudal tumors was included in the NTCP model, improving most correlations significantly, confirming that patients with caudal tumors have a greater probability of developing RP. Conclusion: The incidence of RP correlated significantly with the MLD and MRD of most lung regions, except for the anterior, cranial, and contralateral regions. Weighting the local dose with the local perfusion improved the dose-effect relation for the anterior lung region. Irradiation of caudally located lung tumors resulted in a greater risk of RP than irradiation of tumors located in other parts of the lungs. (C) 2004 Elsevier Inc.
引用
收藏
页码:748 / 758
页数:11
相关论文
共 50 条
[41]   Surgical management of non-small-cell lung cancer [J].
Bamousa, Ahmed ;
AlKattan, Khaled .
ANNALS OF THORACIC MEDICINE, 2008, 3 (06) :S82-S88
[42]   Anthropometric measurements in non-small-cell lung cancer [J].
Giovanni Mantovani .
Supportive Care in Cancer, 2002, 10 :439-439
[43]   Mediastinal staging of non-small-cell lung cancer [J].
Dhillon, Samjot Singh ;
Dhillon, Jaspreet Kaur ;
Yendamuri, Sai .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (06) :835-851
[44]   The systemic treatment of non-small-cell lung cancer [J].
Propper, D ;
Talbot, DC .
ANNALS OF ONCOLOGY, 1997, 8 (03) :285-290
[45]   Vaccination therapy for non-small-cell lung cancer [J].
Cuppens, Kristof ;
Vansteenkiste, Johan .
CURRENT OPINION IN ONCOLOGY, 2014, 26 (02) :165-170
[46]   Anthropometric measurements in non-small-cell lung cancer [J].
Domenico Ferrigno .
Supportive Care in Cancer, 2002, 10 :440-440
[47]   Molecular pathology of non-small-cell lung cancer [J].
Breuer, RHJ ;
Postmus, PE ;
Smit, EF .
RESPIRATION, 2005, 72 (03) :313-330
[48]   Resistance to chemoimmunotherapy in non-small-cell lung cancer [J].
Hochmair, Maximilian Johannes .
CANCER DRUG RESISTANCE, 2020, 3 (03) :445-453
[49]   Radiotherapy for non-small cell lung cancer [J].
Jassem, J .
LUNG CANCER, 2001, 34 :S177-S180
[50]   Radiotherapy of non-small cell lung cancer [J].
Jassem, J .
8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, :207-214